USFDA successfully inspects Carbogen Amcis’s manufacturing sites in Neuland and Aarau
The inspections concluded with no Form 483 observations or significant critical findings
The inspections concluded with no Form 483 observations or significant critical findings
Renews GMP certifications for India and Malaysia sites
A five-day inspection was concluded successfully with no critical and no major observations raised
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
The business serves the healthcare and laboratory sectors on the west coast of the United States.
Subscribe To Our Newsletter & Stay Updated